Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)

Abstract Background Efficacy and safety of human monoclonal antibody erenumab used for migraine prophylaxis have been shown in clinical studies. APOLLON is an open-label, multi-center, single arm study, which permits dose adjustments of erenumab and includes an option for a drug holiday. The finding...

Full description

Bibliographic Details
Published in:The Journal of Headache and Pain
Main Authors: Hartmut Göbel, Eugen Schlegel, Kathrin Jaeger, Sonja Ortler, Lea Leist
Format: Article
Language:English
Published: BMC 2024-09-01
Subjects:
Chronic migraine
Episodic migraine
Monoclonal antibody
Erenumab
Long-term safety
Tolerability
Online Access:https://doi.org/10.1186/s10194-024-01860-w

Internet

https://doi.org/10.1186/s10194-024-01860-w

Similar Items